Bank of America
TBIO

Bank of America’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bank of America’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26,936
Closed -$741K – 8636
2021
Q2 		$741K Sell
26,936
-7,383
-22% -$145K ﹤0.01% 5141
2021
Q1 		$565K Buy
34,319
+13,630
+66% +$311K ﹤0.01% 5261
2020
Q4 		$382K Sell
20,689
-52,162
-72% -$934K ﹤0.01% 5186
2020
Q3 		$992K Buy
72,851
+44,366
+156% +$684K ﹤0.01% 4213
2020
Q2 		$511K Buy
28,485
+15,223
+115% +$230K ﹤0.01% 4604
2020
Q1 		$132K Sell
13,262
-1,389
-9% -$11.4K ﹤0.01% 5360
2019
Q4 		$120K Sell
14,651
-1,833
-11% -$16.9K ﹤0.01% 5916
2019
Q3 		$163K Buy
16,484
+5,141
+45% +$48.5K ﹤0.01% 5786
2019
Q2 		$144K Buy
11,343
+4,920
+77% +$51.9K ﹤0.01% 5810
2019
Q1 		$65K Sell
6,423
-2,328
-27% -$17.9K ﹤0.01% 6095
2018
Q4 		$65K Buy
8,751
+6,756
+339% +$49.5K ﹤0.01% 6107
2018
Q3 		$20K Buy
+1,995
New +$23.2K ﹤0.01% 6508

Bank of America's TBIO Position: Q3 2021 in Review

Bank of America sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 26,936 shares — an estimated $741K sold.

Bank of America first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $992K in Q3 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Bank of America reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bank of America sold 26,936 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $741K.
  • Bank of America first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Bank of America's Translate Bio, Inc. Common Stock position peaked at $992K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Bank of America's 13F filing for Q3 2021, filed 15 Nov 2021.